Notes
2016 Canadian dollars
gemcitibine and nanoparticle albumin-bound (nab) paclitaxel
Reference
Coyle D, et al. Cost-Effectiveness Analysis of Systemic Therapies in Advanced Pancreatic Cancer in the Canadian Health Care System. Value in Health : 3 Jan 2017. Available from: URL: http://dx.doi.org/10.1016/j.jval.2016.11.002
Rights and permissions
About this article
Cite this article
FOLFIRINOX cost effective for advanced pancreatic cancer. PharmacoEcon Outcomes News 771, 14 (2017). https://doi.org/10.1007/s40274-017-3725-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3725-1